Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative Neoplasms.

American journal of clinical pathology - 8 Sept 2021

Li Yanchun, Beck Rose C, Moore Erika M

Abstract excerpt

OBJECTIVES: Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are a group of rare and heterogeneous hematopoietic disorders that frequently present a diagnostic challenge. Here we present our institutional experience with next-generation sequencing (NGS), together with morphologic, flow cytometric, and cytogenetic evaluation, in the diagnosis of MDS/MPN, with particular emphasis on MDS/MPN unclassifiable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Cytogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to High-Throughput Nucleotide Sequencing

Share to Immunophenotyping

Share to Mutation Rate

Share to Myelodysplastic-Myeloproliferative Diseases

Share to Myeloproliferative Disorders

Source

Identifiers

PMID: 33877292
DOI: 10.1093/ajcp/aqaa281

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathogenic Mutations and Atypical Flow Cytometric Findings Characterize the Majority of Unclassifiable Myelodysplastic/Myeloproliferative Neoplasms.PMID 33877292Read ↗

The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.Semantic proximity Read ↗

Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes.Semantic proximity Read ↗

Genomics of myelodysplastic/myeloproliferative neoplasm.Semantic proximity Read ↗

Advances in myelodysplastic/myeloproliferative neoplasms.Semantic proximity Read ↗

Genetic Aspects of Myelodysplastic/Myeloproliferative NeoplasmsSemantic proximity Read ↗

Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative NeoplasmsSemantic proximity Read ↗

Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms.Semantic proximity Read ↗

Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.Semantic proximity Read ↗

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms.Semantic proximity Read ↗

Myeloproliferative Neoplasms: Contemporary Review and Molecular Landscape.Semantic proximity Read ↗

Morphologic findings and mutational profiles of myelodysplastic neoplasms with normal versus abnormal karyotype.Semantic proximity Read ↗

Molecular findings in myeloid neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.